The name of “Pierre Fabre” definitively being associated with the spirit of “Therapeutic innovation”, the company “Pierre Fabre Médicament”, in memory of its founder, and in partnership with the French Medicinal Chemistry Society, has decided to award a decisive action, a scientific discovery, an innovative technology contributing to a substantial therapeutic innovation. This contribution may rise from the very early phase of research and the aim of this prize is to nominate a talented researcher.
The Jury is composed of 6 members:
The Jury is chaired by the President of the SCT.
Pierre Fabre Award recipients: